Amicus Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 05 2022 - 7:00AM
Amicus Therapeutics (Nasdaq: FOLD) today announced that management
will present at the 40th Annual J.P. Morgan Healthcare Conference,
being held virtually on Wednesday, January 12, 2022 at 3:45 p.m.
E.T.
A live audio webcast of the presentation can also be accessed
via the investors section of the Amicus Therapeutics corporate
website at https://ir.amicusrx.com/events-and-presentations.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated
biotechnology company focused on discovering, developing and
delivering novel high-quality medicines for people living with rare
metabolic diseases. With extraordinary patient focus, Amicus
Therapeutics is committed to advancing and expanding a robust
pipeline of cutting-edge, first- or best-in-class medicines for
rare metabolic diseases. For more information please visit the
company’s website at www.amicusrx.com, and follow us on Twitter and
LinkedIn.
CONTACT:
Investors:Andrew
FaughnanExecutive Director, Investor
Relationsafaughnan@amicusrx.com(609) 662-3809
Media:Diana MooreHead of Global
Corporate Affairs & Communicationsdmoore@amicusrx.com(609)
662-5079
FOLD–G
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Apr 2023 to Apr 2024